JAMA’s Post

The recording from the recent ESE Talks… Clinical Management of Androgen Insensitivity Syndrome Before and During Transition is now available. Watch the video now! https://ow.ly/kf6g50Qnt12

Listen to a discussion of "Arteriovenous Access for Hemodialysis" in this JAMA Clinical Review. https://ja.ma/3IDxwrL

🎉 Check out our latest paper A Retrospective Analysis of the Clinical Effectiveness of Tigecycline in the Treatment of Clostridioides difficile-Associated Diarrhea https://lnkd.in/gMkshdU3 #antimicrobialstewardship #Clostridioidesdifficile #Tigecycline

Is inadequate risk stratification diluting hazard ratio estimates in randomized clinical trials? You decide - take a look at this paper.

📰Read more about Hera's positive interim results from our clinical diagnostic study here: https://bwnews.pr/3Wjxspa #AdvancingTheStandardOfCare #FromSurgicalToSimple

Read more about Hera’s Interim results. #endometriosisdiagnostic

For the clinical studies, which was used as the primary indicator of effectiveness? a. Increase in factor IX level b. Improvement in target joints c. Ability to stop prophylaxis d. Annual bleeding rate (ABR)

📰Read more about Hera's positive interim results from our clinical diagnostic study here: https://yhoo.it/4aNDIcR #AdvancingTheStandardOfCare #FromSurgicalToSimple

Experts gathered at the Milken Institute Global Conference this week to discuss potential strategies to expand diversity in clinical trials. If you are planning a clinical trial and would like some support with your protocol or study design, let's have a conversation! #medicaldevice #diagnostic #clinicaltrials

Arshad M. Khanani on the delicate balance between optimizing data collection and minimizing burden on patients in clinical trials. Listen to the full discussion here: https://lnkd.in/g2NjVcPD?